MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Patients experiencing peak-dose dyskinesia use re-distribution of involuntary movement amplitude throughout their body to minimize the functional impact of dyskinesia

K. Lebel, E. Goubault, S. Bogard, C. Duval (Montréal, QC, Canada)

Meeting: 2018 International Congress

Abstract Number: 76

Keywords: Dyskinesias

Session Information

Date: Saturday, October 6, 2018

Session Title: Drug-Induced Movement Disorders

Session Time: 1:45pm-3:15pm

Location: Hall 3FG

Objective: To investigate the presence of a strategy in dyskinesia amplitude re-distribution enabling patients to perform motor tasks.

Background: In Parkinson’s disease (PD), occurrence of dyskinesia is considered one major side effect of long-term use of antiparkinsonian drugs. As a result, clinicians tend to delay its use in the treatment of PD, despite its proven higher efficacy to counteract disabling PD symptoms. Nevertheless, it seems that many patients facing dyskinesia are still able to function adequately, leading to hypothesize that these patients have strategies to alleviate the impact of dyskinesia on their ability to function.

Methods: 45 patients living with PD (mean age = 65.4 ± years old) and experiencing choreic-type, peak-dose dyskinesia were asked to perform a geostationary task where they were required to stabilize a glass of water at eye level for 15 seconds. Whole-body kinematics data were acquired with inertial measurement units (IMUs) while doing so. Energy deployed by each body segment during the task was extracted from accelerometric data, and its distribution among the body segments with time, analyzed.

Results: At initial glass stabilisation, most of the energy was allocated to segments other than the one specifically involved in the movement (i.e. the hand). Although steady for the first few seconds of the stabilisation phase, data revealed that there was a progressive transfer of energy distribution with the hand taking most of the energy, hence generating displacement of the glass of water. Subset analysis using the energy level at rest to divide the group into quartiles have shown that patients with lower levels of dyskinesia at rest behaved differently from the rest of the group; most of the energy remained at hand level throughout the stabilisation phase, although the importance of the hand also increased after a certain stabilisation period.

Conclusions: Analysis of energy distribution suggest that patients experiencing dyskinesia have developed strategies to enable them to perform the required tasks, but that this strategy can only be maintained for a certain period before “re-emerging” dyskinesia occurs.

To cite this abstract in AMA style:

K. Lebel, E. Goubault, S. Bogard, C. Duval. Patients experiencing peak-dose dyskinesia use re-distribution of involuntary movement amplitude throughout their body to minimize the functional impact of dyskinesia [abstract]. Mov Disord. 2018; 33 (suppl 2). https://www.mdsabstracts.org/abstract/patients-experiencing-peak-dose-dyskinesia-use-re-distribution-of-involuntary-movement-amplitude-throughout-their-body-to-minimize-the-functional-impact-of-dyskinesia/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/patients-experiencing-peak-dose-dyskinesia-use-re-distribution-of-involuntary-movement-amplitude-throughout-their-body-to-minimize-the-functional-impact-of-dyskinesia/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley